MPH Health Care AG's Q1 Performance Prompts Target Price Increase

First Berlin Equity Research has published a research update on MPH Health Care AG (ISIN: DE000A289V03). Analyst Ellis Acklin has reiterated his BUY rating and increased the price target from €81.00 to €113.00. This change followed a rise in Q1 net asset value (NAV) by 34% year-on-year to €252 million, although it remained stable year-to-date.

Share performances within the MPH portfolio, particularly M1 Kliniken and CR Energy, were balanced during the January-to-March period. This left the NAV per share (NAVPS) at €58.80 by the end of Q1. M1 Kliniken's stock soared by 87% year-to-date following its optimistic mid-term guidance, which forecasts 150 to 200 clinics by the end of 2029. CR Energy also saw a stock price increase after releasing its annual results.

Assuming these upward trends continue, MPH Health Care AG is expected to report a significant NAV increase in their half-year results. The revised target price is mainly due to the increased valuation of M1 Kliniken, reflecting the aggressive growth expectations now included in the mid-term forecasts.